Department of Biomedical Sciences
Andrea Flesken-Nikitin has not added Biography.
If you are Andrea Flesken-Nikitin and would like to personalize this page please email our Author Liaison for assistance.
Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability.
Cancer research May, 2002 | Pubmed ID: 11980640
Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Cancer research Sep, 2002 | Pubmed ID: 12234974
Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice.
Carcinogenesis Feb, 2003 | Pubmed ID: 12584165
Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.
Cancer research Jul, 2003 | Pubmed ID: 12839925
Mammary carcinoma suppression by cellular retinoic acid binding protein-II.
Cancer research Aug, 2003 | Pubmed ID: 12907615
Use of multiphoton imaging for studying cell migration in the mouse.
Methods in molecular biology (Clifton, N.J.) , 2005 | Pubmed ID: 15576922
Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice.
Cancer research Feb, 2005 | Pubmed ID: 15705875
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
Cancer research Aug, 2006 | Pubmed ID: 16912162
Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
Cancer research Jun, 2007 | Pubmed ID: 17553900
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Cancer research Sep, 2007 | Pubmed ID: 17823410
Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.
Carcinogenesis Mar, 2008 | Pubmed ID: 17893233
Toxicity and biomedical imaging of layered nanohybrids in the mouse.
Toxicologic pathology Oct, 2007 | Pubmed ID: 17943654
Core-shell silica nanoparticles as fluorescent labels for nanomedicine.
Journal of biomedical optics Nov-Dec, 2007 | Pubmed ID: 18163823
Role of p53 and Rb in ovarian cancer.
Advances in experimental medicine and biology , 2008 | Pubmed ID: 18546622
Mouse models for cancer stem cell research.
Toxicologic pathology Jan, 2010 | Pubmed ID: 19920280
Frequent downregulation of miR-34 family in human ovarian cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2010 | Pubmed ID: 20145172
Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy.
Translational oncology , 2010 | Pubmed ID: 20563260
Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation.
Developmental biology Oct, 2010 | Pubmed ID: 20624380
Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors.
Hormones & cancer Feb, 2010 | Pubmed ID: 20631921
Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
The American journal of pathology Nov, 2010 | Pubmed ID: 20864684
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2011 | Pubmed ID: 21831840
MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF.
Cell cycle (Georgetown, Tex.) Nov, 2011 | Pubmed ID: 22071625
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche.
Nature Mar, 2013 | Pubmed ID: 23467088
miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment.
Cell reports Mar, 2014 | Pubmed ID: 24630988
Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers.
Molecular & cellular oncology Jul-Sep, 2014 | Pubmed ID: 27308341
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten